Instrumental variables II: instrumental variable application-in 25 variations, the physician prescribing preference generally was strong and reduced covariate imbalance
- PMID: 19345561
- PMCID: PMC2886011
- DOI: 10.1016/j.jclinepi.2008.12.006
Instrumental variables II: instrumental variable application-in 25 variations, the physician prescribing preference generally was strong and reduced covariate imbalance
Abstract
Objective: An instrumental variable (IV) is an unconfounded proxy for a study exposure that can be used to estimate a causal effect in the presence of unmeasured confounding. To provide reliably consistent estimates of effect, IVs should be both valid and reasonably strong. Physician prescribing preference (PPP) is an IV that uses variation in doctors' prescribing to predict drug treatment. As reduction in covariate imbalance may suggest increased IV validity, we sought to examine the covariate balance and instrument strength in 25 formulations of the PPP IV in two cohort studies.
Study design and setting: We applied the PPP IV to assess antipsychotic medication (APM) use and subsequent death among two cohorts of elderly patients. We varied the measurement of PPP, plus performed cohort restriction and stratification. We modeled risk differences with two-stage least square regression. First-stage partial r(2) values characterized the strength of the instrument. The Mahalanobis distance summarized balance across multiple covariates.
Results: Partial r(2) ranged from 0.028 to 0.099. PPP generally alleviated imbalances in nonpsychiatry-related patient characteristics, and the overall imbalance was reduced by an average of 36% (+/-40%) over the two cohorts.
Conclusion: In our study setting, most of the 25 formulations of the PPP IV were strong IVs and resulted in a strong reduction of imbalance in many variations. The association between strength and imbalance was mixed.
Figures
Similar articles
-
Evaluating the validity of an instrumental variable study of neuroleptics: can between-physician differences in prescribing patterns be used to estimate treatment effects?Med Care. 2007 Oct;45(10 Supl 2):S116-22. doi: 10.1097/MLR.0b013e318070c057. Med Care. 2007. PMID: 17909369
-
Evaluating different physician's prescribing preference based instrumental variables in two primary care databases: a study of inhaled long-acting beta2-agonist use and the risk of myocardial infarction.Pharmacoepidemiol Drug Saf. 2016 Mar;25 Suppl 1:132-41. doi: 10.1002/pds.3860. Pharmacoepidemiol Drug Saf. 2016. PMID: 27038359
-
Instrumental variable applications using nursing home prescribing preferences in comparative effectiveness research.Pharmacoepidemiol Drug Saf. 2014 Aug;23(8):830-8. doi: 10.1002/pds.3611. Epub 2014 Mar 24. Pharmacoepidemiol Drug Saf. 2014. PMID: 24664805 Free PMC article.
-
A theoretical exploration of therapeutic monomania as a physician-based instrumental variable.Pharmacoepidemiol Drug Saf. 2020 Jan;29 Suppl 1(Suppl 1):45-52. doi: 10.1002/pds.4757. Epub 2019 May 15. Pharmacoepidemiol Drug Saf. 2020. PMID: 31094048 Free PMC article. Review.
-
Comparative effectiveness research considered methodological insights from simulation studies in physician's prescribing preference.J Clin Epidemiol. 2022 Aug;148:74-80. doi: 10.1016/j.jclinepi.2022.04.020. Epub 2022 Apr 18. J Clin Epidemiol. 2022. PMID: 35447357 Review.
Cited by
-
Using the global randomization test as a Mendelian randomization falsification test for the exclusion restriction assumption.Eur J Epidemiol. 2024 Aug;39(8):843-855. doi: 10.1007/s10654-024-01097-6. Epub 2024 Feb 29. Eur J Epidemiol. 2024. PMID: 38421485 Free PMC article.
-
Comparative Analysis of Instrumental Variables on the Assignment of Buprenorphine/Naloxone or Methadone for the Treatment of Opioid Use Disorder.Epidemiology. 2024 Mar 1;35(2):218-231. doi: 10.1097/EDE.0000000000001697. Epub 2023 Jan 30. Epidemiology. 2024. PMID: 38290142
-
Intravascular imaging during percutaneous coronary intervention: temporal trends and clinical outcomes in the USA.Eur Heart J. 2023 Oct 12;44(38):3845-3855. doi: 10.1093/eurheartj/ehad430. Eur Heart J. 2023. PMID: 37464975 Free PMC article.
-
Medicalising diagnoses and treatment preferences: a retrospective cohort study of throat-related consultations in electronic primary care records.BJGP Open. 2023 Dec 19;7(4):BJGPO.2023.0056. doi: 10.3399/BJGPO.2023.0056. Print 2023 Dec. BJGP Open. 2023. PMID: 37429635 Free PMC article.
-
Generating Practice-Based Evidence in the Use of Guideline-Recommended Combination Therapy for Secondary Prevention of Acute Myocardial Infarction.Pharmacy (Basel). 2022 Nov 3;10(6):147. doi: 10.3390/pharmacy10060147. Pharmacy (Basel). 2022. PMID: 36412823 Free PMC article.
References
-
- Schneeweiss S, Glynn RJ, Tsai EH, Avorn J, Solomon DH. Adjusting for unmeasured confounders in pharmacoepidemiologic claims data using external information: the example of COX2 inhibitors and myocardial infarction. Epidemiology. 2005;16:17–24. - PubMed
-
- Seeger JD, Williams PL, Walker AM. An application of propensity score matching using claims data. Pharmacoepidemiol Drug Saf. 2005;14:465–76. - PubMed
-
- Davey Smith G, Ebrahim S. “Mendelian randomization”: can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol. 2003;32:1–22. - PubMed
-
- McClellan M, McNeil BJ, Newhouse JP. Does more intensive treatment of acute myocardial infarction in the elderly reduce mortality? Analysis using instrumental variables. JAMA. 1994;272:859–66. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
